Manufacturing and Production

Showing 15 posts of 5862 posts found.

fighting_cancer

Looking to the future of oncology

April 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, feature, oncology, pharma

The oncology field moves so quickly that it can be hard to keep track of the latest innovations. Ben Hargreaves …
cystic_fibrosis_insider_interview

Transforming cystic fibrosis treatment

April 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Fred van Goor, Principle Research Fellow at Vertex Pharmaceuticals, discusses his history of work in cystic fibrosis and how the …

One centre for cancer diagnoses trialled

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS England is trialling centres that should be able to provide rapid answers as to whether a patient has cancer …
fda2outsideweb

Alkermes sent reeling as FDA refuses review of depression treatment

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Alkermes, FDA, depression, major depressive disorder, pharma

Alkermes shares were knocked down to their lowest level since October 2016 after it was revealed that the FDA had …

Rumours Allergan is looking to offload $5bn women’s health unit

April 3, 2018 Manufacturing and Production, Sales and Marketing Allergan, Restasis, biotech, drugs, pharma, pharmaceutical

According to a piece by Bloomberg, Allergan is looking at options to divest its women’s health unit in a move …
medimmune_building_cambridge

AZ’s MedImmune signs $200m immuno-oncology partnership with Compugen

April 3, 2018 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, compugen, immunotherapy, oncology, pharma

AstraZeneca’s biologic R&D unit MedImmune is set to enter a partnership with Israeli drug firm Compugen to develop bi-specific and …
celgene_1_02

Celgene’s COO heads to the exit

April 3, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Celgene, Mark Alles, Scott Smith, biotech, drugs, pharma, pharmaceutical

Celgene has had a rough six months, its share price since the beginning of October has dropped from $146 to …

Pfizer seeks tax breaks in return for planned $456m facility

March 28, 2018 Manufacturing and Production, Research and Development Michigan, Pfizer, biotech, drugs, pharma, pharmaceutical, tax break

Pfizer has submitted proposals to officials in Portage, Michigan, for a major expansion of its manufacturing site in the city. …
brexit-referendum-uk-1468255193y2p

Brexit Health Alliance: Brexit and the impact on patient access to medicines

March 28, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brexit Health Alliance, brexit, feature, market access, pharma

On behalf of the Brexit Health Alliance, Sarah Collen, Senior Policy Manager at NHS Confederation, details the potential negative fallout …
abbvie_0

Abbvie pays out over $3m after its testosterone replacement drug leads to heart attack

March 27, 2018 Manufacturing and Production, Sales and Marketing AbbVie, Endo, GSK, androgel, heart attack, pharma

Abbvie has been ordered to pay over $3 million in damages to a man who asserts that the uise of …
headache

Reaction mixed to Biohaven’s migraine drug results

March 27, 2018 Manufacturing and Production, Research and Development Allergan, Biohaven, CGRP, biotech, drugs, migraine, pharma, pharmaceutical

Biohaven is full of confidence in its lead drug, rimegepant, evidenced only a few weeks ago when it decided to …

GSK to take control of Consumer Healthcare in £9.2bn buyout

March 27, 2018 Manufacturing and Production, Sales and Marketing Consumer Health Care, GSK, Novartis, biotech, drugs, horlicks, pharma, pharmaceutical

GSK has announced that it plans to purchase Novartis’ 36.5% stake in the joint Consumer Healthcare Business for a sum …
The Gateway to Local Adoption Series

Latest content